Deerfield Management Company
Growth equityNew York · Growth–Late Stage · 62 people tracked
Investment thesis
Deerfield Management Company pursues healthcare advancement across the full spectrum of the healthcare industry, with primary focus on therapeutics, medical devices, and healthcare services. Leveraging over three decades of operational experience and $16 billion in assets under management, the firm connects capital, people, and technology while utilizing proprietary intelligence capabilities to identify emerging trends. The investment approach is flexible and extends to both development-stage and commercial assets, including acquisition and integration support prior to corporate acquisitions. The firm complements financial returns with a mission-driven foundation focused on global children's health.
Source: firm website, verified Jul 21, 2026.
Team · 62 people
from the firm's website
Frequently asked questions
- What stage does Deerfield Management Company invest at?
- Deerfield Management Company invests at the Growth, Late Stage stages.
- What sectors does Deerfield Management Company focus on?
- Deerfield Management Company focuses on Biotech, Healthtech, Medical Devices.
- Where is Deerfield Management Company located?
- Deerfield Management Company is headquartered in New York, US.
Images
Similar investors
B Capital is a venture capital firm managing over $12 billion in assets with a stage-based fund approach. The firm invests across early to late-stage companies in technology, healthcare, and energy & resilience sectors, with 200+ portfolio companies and 9 global offices.
DCVC is a deep tech venture capital firm with over a dozen years of experience backing entrepreneurs using computational approaches to solve trillion-dollar problems across industries including AI, climate, materials science, robotics, space, and biology.
GV is Alphabet's venture capital arm, established in 2009 as Google Ventures. Operating with long time horizons and over $13 billion in assets under management, the firm invests across technology and life sciences sectors from seed to growth stages, supporting 400 active portfolio companies across North America, Europe, and Israel.
EQT Life Sciences is one of Europe's largest and most experienced life sciences investors, focusing on innovative companies developing therapeutics, medical devices, diagnostics, and healthtech globally. The firm has raised approximately 3.5 billion euros across 12 private funds and 3 investment strategies over its 30-year history.
Summit Partners is a growth-focused investment firm with over 41 years of experience investing in category-leading companies across technology, healthcare and life sciences, and growth products and services. The firm leverages a collaborative approach to support market leaders through both minority and majority investments.